South Korea Biofabrication Market Insight
Published: 16 June 2026 | Report Format: Electronic (PDF)
The South Korea biofabrication market is expected to grow at a rate of 9.38% owing to increasing adoption of tissue engineering technologies, rising regenerative medicine research, expanding bioprinting applications, and growing investments in advanced biomedical manufacturing
South Korea Biofabrication Market Insight Forecasts to 2035
- The South Korea Biofabrication Market Size Was Estimated at USD 298.7 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 9.38% from 2025 to 2035
- The South Korea Biofabrication Market Size is Expected to Rise Around USD 732.5 Million by 2035
Notable Insights for the South Korea Biofabrication Market
- The product-based segmentation indicates that Bioinks, Biomaterials segment holds a commanding position with nearly 54% market share in the South Korea Biofabrication Market during 2025 due to increasing utilization in tissue engineering.
- The application-based segmentation shows that Tissue Engineering, Regenerative Medicine segment dominates with approximately 61% market share in the South Korea Biofabrication Market in 2025 owing to growing demand for advanced biomedical research.
- The global revenue of Organovo Holdings Inc. in fiscal year 2025 was supported by rising demand for biofabrication technologies, tissue engineering platforms, regenerative medicine products.
- Rising investments in 3D bioprinting technologies, while advanced biofabrication technologies improve tissue production precision by nearly 46% and reduce development timelines by approximately 30%
Download the eBook (ToC)
Research Methodologies Used to Analyze the South Korea Biofabrication Market
The South Korea biofabrication market is analyzed through a combination of primary and secondary research methodologies to ensure accurate market intelligence and forecasting. Primary research includes interviews with biotechnology companies, biomedical researchers, healthcare institutions, bioprinting technology providers, and industry specialists. Secondary research involves company reports, government publications, scientific journals, patent databases, healthcare statistics, and biotechnology industry resources. Market sizing, forecasting models, trend analysis, and investment assessments are utilized to evaluate future opportunities and competitive developments.
Decisions Advisors Research Methodology: Trusted Insights for Strategic Decision-Making
What is Decisions Advisors Research?
Decisions Advisors research delivers comprehensive market intelligence through detailed industry analysis, competitive benchmarking, trend forecasting, and data-driven business insights. Our research methodology combines advanced analytical frameworks with extensive primary and secondary research to help organizations make informed and strategic business decisions.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the South Korea Biofabrication Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in South Korea Biofabrication Market
- Horiba Ltd.
- Thermo Fisher Scientific Inc.
- Renishaw plc
- Bruker Corporation
- Agilent Technologies, Inc.
- Shimadzu Corporation
- PerkinElmer Inc.
- WITec GmbH
- B&W Tek, LLC
- Metrohm AG
Recent Developments:
- In February 2026, Rokit Healthcare expanded its biofabrication platform with advanced regenerative medicine solutions for tissue engineering and personalized healthcare applications.
- In September 2025, CELLINK introduced next-generation biofabrication systems integrated with AI-assisted design technologies for biomedical research and tissue development.
Market Segmentation:
South Korea Biofabrication Market, By Product Type
- Bioinks
- Biomaterials
- Bioprinting Systems
- Cell Culture Scaffolds
- Tissue Engineering Platforms
South Korea Biofabrication Market, By Technology
- 3D Bioprinting Technologies
- AI-Assisted Biofabrication Platforms
- Stem Cell Engineering Technologies
- Scaffold-Based Tissue Manufacturing
- Automated Cell Processing Systems
South Korea Biofabrication Market, By Application
- Tissue Engineering
- Regenerative Medicine
- Organ Modeling
- Drug Discovery & Testing
- Biomedical Research
Expert Views:
The growth of the South Korea biofabrication market will be driven by expanding regenerative medicine programs, increasing demand for tissue engineering solutions, and continuous advancements in bioprinting technologies. Integration of artificial intelligence, stem cell engineering, and automated biofabrication platforms will improve production efficiency and research outcomes. Growing investments in personalized medicine, organ modeling, and biomedical innovation will further strengthen market expansion through 2035.
Author: Aditi and Govind By Decisions Advisors and Consulting